Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Seoul: Hakjisa; 2015.
Christensen DL, Bilder DA, Zahorodny W, Pettygrove S, Durkin MS, Fitzgerald RT, et al. Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the autism and developmental disabilities monitoring network. J Dev Behav Pediatrics. 2016;37:1–8.
Scottish Intercollegiate Guidelines Network (SIGN). Assessment, diagnosis and interventions for autism spectrum disorders. Edinburgh: SIGN; 2016.
Textbook Compiliation Committee. Pediatrics of Korean Medicine. revised edn. Seoul: Euisungdang; 2015.
Cho KH, Kim TH, Jin C, Lee JE, Kwon S. The literary trends of herbal prescription Ukgan-san and its application in modern traditional Korean medicine. J Korean Med. 2018;39:17–27.
Wake R, Miyaoka T, Furuya M, Hashioka S, Horiguchi J. Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder. CNS Neurol Disord Drug Targets. 2016;15:551–63.
Muneoka K, Kuwagata M, Ogawa T, Shioda S. Mother/offspring co-administration of the traditional herbal remedy yokukansan during the nursing period influences grooming and cerebellar serotonin levels in a rat model of neurodevelopmental disorders. Cerebellum. 2015;14:86–96.
Fujiwara H, Han Y, Ebihara K, Awale S, Araki R, Yabe T, et al. Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice. BMC Complement Altern Med. 2017;17:195.
Sato R, Kato K, Yamada K, Akama F, Kimoto K, Kimoto K, et al. A case of irritability with autistic disorder in children and adolescents improved by Yokukansan. Psychiatr. 2002;20:693–8.
Wake R, Miyaoka T, Inagaki T, Furuya M, Ieda M, Liaury K, et al. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study. J Child Adolesc Psychopharmacol. 2013;23:329–36.
Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, et al. Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study. BMC Psychiatry. 2012;12:215.
Japanese Pediatric Oriental Medicine Association. Handbook of Kampo treatment for children. Tokyo: Japan Pediatric Medical Publishers; 2015.
KIPC DRUG INFO. [ http://www.health.kr/searchDrug/result_drug.asp?drug_cd=2014091600004 ]. Accessed 31 July 2018.
McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133:872–83.
Lyra L, Rizzo LE, Sunahara CS, Pachito DV, Latorraca COC, et al. What do Cochrane systematic reviews say about interventions for autism spectrum disorders? Sao Paulo Med J. 2017;135:192–201.
Abo Almaali HMM, Gelewkhan A, Mahdi ZAA. Analysis of Evidence-Based Autism Symptoms Enhancement by Acupuncture. J Acupunct Meridian Stud. 2017;10:375–84.
Lee B, Lee J, Cheon JH, Sung HK, Cho SH, Chang GT. The Efficacy and Safety of Acupuncture for the Treatment of Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2018;2018:1057539.
Liu C, Li T, Wang Z, Zhou R, Zhuang L. Scalp acupuncture treatment for children's autism spectrum disorders: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14880.
Shin MS, Kim YH. Standardization study for the Korean version of Childhood Autism Rating Scale: reliability, validity and cut-off score. Korean J Clin Psychol. 1998;17:1–15.
Krug DA, Arick J, Almond P. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry. 1980;21:221–9.
Eaves RC, Williams TO. The reliability and construct validity of ratings for the autism behavior checklist. Psychol Sch. 2006;43:129–42.
Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Am Acad Pediatrics Counc Children Disabil. 2007;120:1183–215.
Yousefi N, Dadgar H, Mohammadi MR, Jalilevand N, Keyhani MR, Mehri A. The Validity and Reliability of Autism Behavior Checklist in Iran. Iran J Psychiatry. 2015;10:144–9.
Aman MG, Singh NN, Stewart AW, Field CJ. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic. 1985;89:492–502.
Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, et al. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord. 2013;43:739–46.
Aman MG, Singh NN, Turbott SH. Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions. Am J Ment Defic. 1987;92:237–40.
Kim SG, Kim OG. Social Maturity Scale Protocol. Seoul: Jungang Aptitude Laboratory; 1995.
Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol. 2002;55:67–76.
Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19:887–97.
Abidin RR, Jung GM, Lee GS, Park JA. Guide to Korean Parenting Stress Index. Seoul: Insight of Psychology; 2008.
Zhou NY, Li YC, Jiang XY. Clinical Observation of Supplemented Lizhong Decoction in Treating Children Autism. J New Chinese Med. 2015;47(6):200–2.
Sun YB, Song HJ, Feng TZ, Yuan Y, Zhao NX. Comprehensive treatment of 60 cases of childhood autism. Liaoning J Tradit Chin Med. 2016;43:2105–8.
Bang M, Lee SH, Cho SH, Yu SA, Kim K, Lu HY, et al. Herbal Medicine Treatment for Children with Autism Spectrum Disorder: A Systematic Review. Evid Based Complement Alternat Med. 2017;2017:8614680.
Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill Summ. 2016;65:1–23.
Shin SH. Understanding of high-functioning autism spectrum disorder. In: 2019 Spring Conference and Workshop. Seoul: Korean Association for Persons with Autism, Korean Academy for Autism Spectrim Disorder; 2019.
Tamano H, Yusuke E, Ide K, Takeda A. Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats. Exp Anim. 2016;65:353–61.
Ito A, Shin N, Tsuchida T, Okubo T, Norimoto H. Antianxiety-like effects of Chimpi (dried citrus peels) in the elevated open-platform test. Molecules. 2013;18:10014–23.
Murayama C, Watanabe S, Nakamura M, Norimoto H. Inhibitory Activity of Yokukansankachimpihange against Nerve Growth Factor-Induced Neurite Growth in Cultured Rat Dorsal Root Ganglion Neurons. Molecules. 2015;20:14959–69.
Aizawa R, Kanbayashi T, Saito Y, Ogawa Y, Sugiyama T, Kitajima T, et al. Effects of Yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci. 2002;56:303–4.
Shin HJ, Lee B, Lee J, Chang GT. A clinical study of treating autism spectrum disorder in childhood. J Pediatr Korean Med. 2017;31:49–60.